glp 1 resistance Anti-Inflammatory and Anti-Oxidative Effects of GLP1-RAs and SGLT2i: The Guiding Star Towards Cardiovascular Protection in Type 2 Diabetes The current significance and prospects

In this study, 4076 patients living with T2DM and either a history of CVD (90%) or kidney disease and at least one other cardiovascular risk factor were randomized to receive once-weekly 4 mg or 6 mg efpeglenatide injection or placebo (median follow-up 1.81 years)

FM 2.0 principle: Food is more than fuelit's an information system for gene expression and hormonal intelligence

This peptide, which they named 'exendin-4', not only stimulated insulin secretion in the same way as GLP-1 but also had the advantage that it remained active for more than two hours after subcutaneous injection

doi: 10.1016/j.xcrm.2022.100813